Pfizer raises 2021 sales forecast for Covid vaccines to US$26 billion

US drug maker Pfizer has today raised its sales forecast for Covid-19 jabs from US$15 billion previously to US$26 billion. – EPA pic, May 4, 2021.

PFIZER sharply increased its projections for 2021 revenues and profits today, citing much higher sales from its Covid-19 vaccine sales.

The drug maker now estimates 2021 revenues of US$26 billion (RM107.2 billion) from the vaccine, up from US$15 billion previously and reflecting 1.6 billion doses expected to be delivered this year under contracts signed through mid-April.

Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one (1) week free access!

Subscribe Now!

Sign up or sign in here to comment.